Cell Surface Protein C23 Affects EGF-EGFR Induced Activation of ERK and PI3K-AKT Pathways

Journal of Molecular Neuroscience

Volumn 55, Issue 2, 2015, Pages 519-524

  Lv, Shunzeng ^a,b   Dai, Congxin ^a   Liu, Yuting ^a   Sun, Bowen ^a   Shi, Ranran ^b   Han, Mingzhi ^b   Bian, Ruixiang ^b   Wang, Renzhi ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

C23; EGF; ERK; Glioblastoma; PI3K AKT

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NUCLEOLIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN; PROTEIN KINASE B; RNA BINDING PROTEIN;

CELL MOTION; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; NERVE CELL; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA-BINDING PROTEINS;

EID: 84939880794     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-014-0375-7     Document Type: Article

References (24)

1. Agnihotri S, Burrell KE, Wolf A, Jalali S, Hawkins C, Rutka JT, Zadeh G (2013) Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies. Arch Immunol Ther Exp (Warsz) 61:25–41
2. Dai H, Song D, Xu J, Li B, Hertz L, Peng L (2013) Ammonia-induced Na, K-ATPase/ouabain-mediated EGF receptor transactivation, MAPK/ERK and PI3K/AKT signaling and ROS formation cause astrocyte swelling. Neurochem Int 63:610–625
3. Dent P (2014) Crosstalk between ERK, AKT, and cell survival. Cancer Biol Ther 15:245–246
4. Destouches D, El Khoury D, Hamma-Kourbali Y, Krust B, Albanese P, Katsoris P, Guichard G, Briand JP, Courty J, Hovanessian AG (2008) Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin. PLoS One 3:e2518
5. Fan QW, Cheng C, Knight ZA, Haas-Kogan D, Stokoe D, James CD, McCormick F, Shokat KM, Weiss WA (2009) EGFR signals to mTOR through PKC and independently of Akt in glioma. Sci Signal 2:ra4
6. Galzio R, Rosati F, Benedetti E, Cristiano L, Aldi S, Mei S, D’Angelo B, Gentile R, Laurenti G, Cifone MG, Giordano A, Cimini A (2012) Glycosilated nucleolin as marker for human gliomas. J Cell Biochem 113:571–579
7. González V, Guo K, Hurley L, Sun D (2009) Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein. J Biol Chem 284:23622–23635
8. Lawton CD, Nagasawa DT, Yang I, Fessler RG, Smith ZA (2012) Leptomeningeal spinal metastases from glioblastoma multiforme: treatment and management of an uncommon manifestation of disease. J Neurosurg Spine 17:438–448
9. Li YP, Busch RK, Valdez BC, Busch H (1996) C23 interacts with B23, a putative nucleolar-localization-signal-binding protein. Eur J Biochem 237:153–158
10. Lv S, Zhang J, Han M, Wang W, Zhang Y, Zhuang D, Shi R, Bian R, Yao C (2014) Nucleolin Promotes TGF-β Signaling Initiation via TGF-β Receptor I in Glioblastoma.J Mol Neurosci PMID:24682943.
11. Paugh BS, Paugh SW, Bryan L, Kapitonov D, Wilczynska KM, Gopalan SM, Rokita H, Milstien S, Spiegel S, Kordula T (2008) EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells. FASEB J 22:455–465
12. Qiu W, Zhou F, Zhang Q, Sun X, Shi X, Liang Y, Wang X, Yue L (2013) Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer. APMIS 121:919–925
13. Qiu C, Xie Q, Zhang D, Chen Q, Hu J, Xu L (2014) GM-CSF induces cyclin D1 expression and proliferation of endothelial progenitor cells via PI3K and MAPK signaling. Cell Physiol Biochem 33:784–795
14. Schokoroy S, Juster D, Kloog Y, Pinkas-Kramarski R (2013) Disrupting the oncogenic synergism between nucleolin and Ras results in cell growth inhibition and cell death. PLoS One 8:e75269
15. Sletten T, Kostas M, Bober J, Sorensen V, Yadollahi M, Olsnes S, Tomala J, Otlewski J, Zakrzewska M, Wiedlocha A (2014) Nucleolin regulates phosphorylation and nuclear export of fibroblast growth factor 1 (FGF1). PLoS One 9:e90687
16. Tsubaki M, Satou T, Itoh T, Imano M, Ogaki M, Yanae M, Nishida S (2012) Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway. Toxicol Appl Pharmacol 259:402–410
17. Turck N, Lefebvre O, Gross I, Gendry P, Kedinger M, Simon-Assmann P, Launay JF (2006) Effect of laminin-1 on intestinal cell differentiation involves inhibition of nuclear C23. J Cell Physiol 206:545–555
18. Wakabayashi T (2011) Clinical trial updates for malignant brain tumors. Rinsho Shinkeigaky 51:853–856
19. Wang Y, Mao M, Xu JC (2011) Cell-surface nucleolin is involved in lipopolysaccharide internalization and signalling in alveolar macrophages. Cell Biol Int 35:677–685
20. Wang HY, Yang SL, Liang HF, Li CH (2014) HBx protein promotes oval cell proliferation by up-regulation of cyclin D1 via activation of the MEK/ERK and PI3K/Akt pathways. Int J Mol Sci 15:3507–3518
21. Watanabe T, Hirano K, Takahashi A, Yamaguchi K, Beppu M, Fujiki H, Suganuma M (2010) Nucleolin on the cell surface as a new molecular target for gastric cancer treatment. Biol Pharm Bull 33:796–803
22. Wu DM, Zhang P, Liu RY, Sang YX, Zhou C, Xu GC, Yang JL, Tong AP, Wang CT (2014) Phosphorylation and changes in the distribution of nucleolin promote tumor metastasis via the PI3K/Akt pathway in colorectal carcinoma. FEBS Lett 588:1921–1929
23. Xie J, Ma YH, Wan M, Zhan RY, Zhou YQ (2014) Expression of dedifferentiation markers and multilineage markers in U251 glioblastoma cells with silenced EGFR and FGFR genes. Oncol Lett 7:131–136
24. Xu Z, Joshi N, Agarwal A, Dahiya S, Bittner P, Smith E, Taylor S, Piwnica-Worms D, Weber J, Leonard JR (2012) Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest. J Neuro-Oncol 108:59–67